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The UmuC subunit of the E. coli DNA polymerase
V shows a unique interaction with the β-clamp
processivity factor
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Abstract
Background: Strict regulation of replisome components is essential to ensure the accurate transmission of the
genome to the next generation. The sliding clamp processivity factors play a central role in this regulation,
interacting with both DNA polymerases and multiple DNA processing and repair proteins. Clamp binding partners
share a common peptide binding motif, the nature of which is essentially conserved from phage through to
humans. Given the degree of conservation of these motifs, much research effort has focussed on understanding
how the temporal and spatial regulation of multiple clamp binding partners is managed. The bacterial sliding
clamps have come under scrutiny as potential targets for rational drug design and comprehensive understanding
of the structural basis of their interactions is crucial for success.
Results: In this study we describe the crystal structure of a complex of the E. coli β-clamp with a 12-mer peptide
from the UmuC protein. UmuC is the catalytic subunit of the translesion DNA polymerase, Pol V (UmuD’2C). Due to
its potentially mutagenic action, Pol V is tightly regulated in the cell to limit access to the replication fork. Atypically
for the translesion polymerases, both bacterial and eukaryotic, Pol V is heterotrimeric and its β-clamp binding motif
(357 QLNLF 361) is internal to the protein, rather than at the more usual C-terminal position. Our structure shows that
the UmuC peptide follows the overall disposition of previously characterised structures with respect to the highly
conserved glutamine residue. Despite good agreement with the consensus β-clamp binding motif, distinct variation
is shown within the hydrophobic binding pocket. While UmuC Leu-360 interacts as noted in other structures, Phe-
361 does not penetrate the pocket at all, sitting above the surface.
Conclusion: Although the β-clamp binding motif of UmuC conforms to the consensus sequence, variation in its
mode of clamp binding is observed compared to related structures, presumably dictated by the proximal aspartate
residues that act as linker to the poorly characterised, unique C-terminal domain of UmuC. Additionally, interactions
between Asn-359 of UmuC and Arg-152 on the clamp surface may compensate for the reduced interaction of Phe-361.
Keywords: Translesion synthesis, Sliding clamp, Processivity factor, UmuC, Regulation
Background
Temporal and spatial regulation of events during DNA
replication and repair is crucial to the maintenance of
genome stability and accurate transmission of the gen-
ome to the next generation. Protein-protein interactions
are central to such regulation within the E. coli replisome
and characterisation of these interactions is critical to our
understanding of these complex, dynamic processes [1].
Processivity factors play an integral role involving both
protein-protein and protein-DNA interactions in regula-
tion of events at the replication fork [2,3].
Processivity factors, or sliding clamps, such as the pro-
karyotic β-clamp and eukaryotic and archaeal proliferat-
ing cell nuclear antigen (PCNA), show a high degree of
structural conservation despite limited sequence identity
[4]. These ring–shaped proteins topologically encircle
DNA providing a sliding platform for the majority of
DNA polymerases and many DNA-interacting proteins.
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Most typically these partners bind to the processivity
factor via a conserved motif (β-clamp: QL[S/D]LF and
PCNA: Qxx[I/L/M]xxF[F/Y]) at their extreme N- or C-
terminus, although internal motifs are not unknown
[5,6]. Structures of binding partners in complex with
processivity factors have demonstrated that a variety
of modulating interfaces exist beyond this principal
motif [7-9]. Given the number of postulated binding
partners of sliding clamps such interfaces are clearly
important in adding levels of subtlety to processivity
factor access and the establishment of binding hier-
archies [10].
The involvement of processivity factors in the regula-
tion of the Y-family of translesion polymerases has
attracted much research interest over the last decade.
These polymerases are potentially mutagenic and as
such their access to the primer-template terminus must
be strictly regulated. The principal interaction motifs
have been widely characterised structurally as well as by
protein complexes, showing modulating, regulatory in-
terfaces [7,11-13]. Four of the five known E. coli poly-
merases, including the translesion polymerases IV and
V, are known to require functional interaction with the
β-clamp for in vivo activity and to date structures of
the clamp-binding peptides of Pol II, Pol III and Pol IV
have been solved in complex with the β-clamp leaving
only the UmuC motif uncharacterised [11,14].
The bacterial β-clamps have attracted much interest
as potential targets for antibiotic therapy since all five
DNA polymerases interact with the same site on the
clamp [15] and critically, inhibitors of prokaryotic
polymerase binding do not inhibit eukaryotic PCNA-
binding partner interactions [14]. Rational design of
inhibitors of this binding pocket could lead to develop-
ment of broad spectrum and species-specific antibiotics
and it is of great importance to thoroughly charac-
terise binding pocket interactions, since inhibitors
can differentially affect the various E. coli DNA poly-
merases [14].
Pol V is a heterotrimer consisting of the catalytic
UmuC subunit and a homodimer of UmuD’ and was ori-
ginally identified as being central to damage-induced
mutagenesis. Given this mutagenic potential it is subject
to many levels of regulation [16]. It is transcriptionally
regulated as part of the E. coli SOS response and under-
goes further post-translational modification whereby
the UmuD subunit undergoes RecA-stimulated auto-
catalytic cleavage to produce the functional UmuD’2C
heterotrimer. A role for UmuD is emerging in the regu-
lation of mutagenesis and in control of polymerase
access to the sliding clamp [17,18]. The β-clamp-UmuC
interaction provides a further level of regulation and
Dalrymple and others identified an internal β-binding
motif 357QLNLF361, located on the linker region between
the little finger (LF) domain and the C-terminal domain
(CTD) of UmuC [5]. Although the translesion polymer-
ases share the overall right hand fold of classical polymer-
ases, comprising a palm, fingers and thumb domain, the
family possesses a unique LF domain crucial to lesion by-
pass. In Pol IV, the β-binding motif is proximal to the LF
and the β-binding motif of UmuC motif is in an analogous
position (Figure 1). The CTD of UmuC is of unknown
function and is presumably a later acquisition. Pol V is the
only family member to have accessory subunits in the
form of the UmuD’2 homodimer. Analysis of UmuC mu-
tants demonstrated the functional importance of the CTD
in Pol V and it has been suggested that the UmuC CTD
mediates the interaction between UmuC and UmuD’2 in
the Pol V heterotrimer [19].
Internal β-binding and PCNA-interacting peptide
(PIP) boxes are less common than those located at the
extreme termini but they are by no means unknown.
The main E. coli replicase Pol III catalytic subunit has
been postulated to possess two β-binding motifs, one in-
ternal and one at the extreme C-terminus, although
there is some debate as to the relative roles of the two
sites, with the C-terminal peptide solved in complex
with the β-clamp [14,20,21]. The peptide-binding
pocket of the β-clamp has been proposed as a target for
rational drug design to disrupt bacterial growth and a
candidate molecule co-crystallised with the clamp
[14,22]. We wished to complete the structural analysis
of the E. coli DNA polymerase β-binding motifs by
solving the UmuC clamp-binding peptide in complex
with the β-clamp.
Methods
Expression and purification of β-clamp
Plasmid pACYC11-dnaN encoding full length β-clamp
with an N-terminal His-tag was transformed into E. coli
B834 (DE3) expression strain [23]. Fresh transformants
were grown in LB broth containing 34 μg/ml chloram-
phenicol at 37°C. Cells were induced with IPTG (0.1 mM
final concentration) at OD600 = 0.6-0.8, and were further
incubated overnight at 25°C. The cells were then harvested
by centrifugation, lysed by sonication in buffer A (50 mM
HEPES pH 7.0, 200 mM NaCl, 20 mM imidazole) and the
soluble fraction obtained by centrifugation at 15,000 x g for
30 min at 4°C. The soluble fraction was then applied to a
batch Talon affinity column (Clontech) equilibrated in buf-
fer A, washed with 30 column volumes of buffer A and
eluted in a small volume of buffer A supplemented to
300 mM imidazole. The protein was then applied directly
to a 26/60 Superdex 200 column equilibrated and run in
50 mM HEPES pH 7.0 and 200 mM NaCl. Fractions
containing purified β-clamp were pooled and concentrated
to 25 mg/ml.
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Dylight649-Pol V synthetic peptide
Purified peptide (352QGVAQLNLFDD363) corresponding
to the β-clamp binding region of UmuC was linked with
Dylight649 chromophore at the N-terminus (Cambridge
Peptides). A cysteine bridge was included to permit link-
age of the chromophore to the peptide i.e. (Dylight649-
C-352QGVAQLNLFDD363). The peptide was suspended
in 50 mM HEPES, 200 mM NaCl to a final concentra-
tion of 1 mM.
Purification and crystallization of β-clamp in complex
with Dylight649-Pol V synthetic peptide
Purified β-clamp, at a concentration of 0.6 mM was
mixed with an excess of the Dylight649-UmuC synthetic
peptide, at 1 mM. After 1 hour incubation at room
temperature, the clamp-peptide complex was purified by
size-exclusion chromatography (10/300 Superdex 200
column) and concentrated to 15 mg/ml. The complex
was crystallized in a solution containing 200 mM cal-
cium acetate, 200 mM MES pH 6.5, 14% PEG 6000
using the sitting drop method at 12°C, in a 1:1 ratio with
the well solution. Crystals were cryo-protected by
transfer to equilibrated well solution supplemented with
15% PEG 400 prior to freezing.
Structure solution
Data were collected at Diamond Light Source (IO2) and
processed using iMOSFLM and the CCP4 suite [24,25].
Molecular replacement was performed using Balbes,
producing a clear solution utilising [PDB:3D1G] as a
search model [14,26]. Clear density was visible in a Fo-
Fc map in the expected location of the UmuC peptides.
However, to avoid bias, initial building of the peptide
backbones was performed using Buccaneer, followed by
rounds of manual model building using Coot and refine-
ment using Refmac 5, interspersed with monitoring using
Molprobity [27-30]. Tight NCS restraints were employed
during refinement, excluding regions where inspection of
maps suggested deviation between the subunits. Initial
TLS parameters for refinement were calculated using the
TLS Motion Determination Server (http://skuld.bmsc.
washington.edu/~tlsmd/). Coordinates have been depos-
ited with the PDB [PDB:4K74].
346QLVLGL351
QL(SD)LF
779QLGLF783
357QLNLF361
920QADMF924
1154QVELEFD1160
Pol II (1-783)
Pol III (α subunit) 1-1160
Pol IV (1-351)
Pol V (UmuC subunit) 1-422
consensus
PF T LF CTD
357QLNLF361
A
B
P
Figure 1 The β-clamp binding motifs. A. Schematic to show the relative positions and sequences of the β-clamp binding motifs in Pol II, Pol
III, Pol IV and Pol V. Shown for comparison is the consensus β-binding motif as identified by Dalrymple and others (2001) [5]. B. A more detailed
schematic of Pol V showing the β-binding motif in relation to known domains. Domains: F – finger; P – palm, T – thumb, LF – little finger and
CTD – C-terminal domain.
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Results
Global architecture
The structure of the E. coli β-clamp was solved in com-
plex with a fluorophore-labelled synthetic UmuC β-
binding peptide to 2.5 Å resolution (Table 1). Utilisation
of a labelled peptide, as described previously by
Georgescu and others [14], permitted the ready identifi-
cation of protein-peptide complex in the crystallisation
trays due to a marked blue colouration of the crystals
(Figure 2), over-coming a significant impediment to so-
lution of β-clamp complexes due to the fact that un-
bound clamp protein crystallises very readily. Analysis of
the complex via size exclusion chromatography (Figure 2)
showed the expected slight reduction in elution volume,
consistent with a small increase in size of the clamp-
peptide complex versus the clamp alone. The resulting
fractions were bright blue in colour, again consistent
with the formation of a complex between the clamp pro-
tein and UmuC peptide.
The asymmetric unit contains a single β-clamp dimer
with a peptide bound to each monomer. Due to insuffi-
cient electron density to confidently model loop regions,
β-clamp Chain A residues 22–26 and 209–211 and
Chain B residues 22–23 were excluded during model
building. The terminal residue of the hexa-histidine tag
has been modelled in both subunits, with the remain-
der of the tag presumably disordered. The C-terminal
residues (Arg-365 and Leu-366) in both β-clamp chains
(A and B) were too disordered to permit modelling
with any degree of confidence, as were the side chains
of Arg-73 (A), His-148 (A), Arg-100 (B) and Phe-230
(B). The 12-mer peptide consisted of Dylight649-C-QG
VAQLNLFDD363, with a cysteine included to permit
linkage of the fluorophore to the peptide. The density
for peptide chain D (associated with β-clamp chain B)
(Additional file 1: Figure S1) was better defined than
peptide chain C (associated with β-clamp chain A). Varia-
tions in occupancy have previously been observed in β-
clamp-peptide complexes, with one site being occluded by
crystal packing [11,14]. Residues 356AQLNLF361 were
modelled for chain D and 357QLNLF361 for chain C, com-
prising the core β-binding motif of the UmuC peptide,
with the remaining residues presumably disordered. NCS
restraints were not applied to the terminal modelled resi-
due for the peptide, Phe-361, since inspection of the 2Fo-
Fc and Fo-Fc maps during refinement suggested variation
for this residue between the two peptide chains. Areas of
positive density surrounding the modelled residue in chain
C are suggestive of some variation in position of the side
chain but were not sufficiently well-defined to support in-
clusion of alternate conformations within the model.
Aside from this residue the two peptide chains are very
similar. The disposition of secondary structural elements
in the β/UmuC peptide complex is retained between the
uncomplexed β-clamp structure [PDB:2POL] and β-clamp
complexes with clamp-binding peptides from Pols II
[PDB:3D1E], III [PDB:3D1F] and IV [PDB:1OK7]. For ref-
erence, key interacting residues from each of these com-
plexes are mapped in Additional file 1: Figure S2. Amino
acid numbers given will refer to chains B (β-clamp) and D
(UmuC peptide) of the complex, unless otherwise stated.
Interaction of the UmuC peptide with β-clamp
Unlike the neighbouring Ala-356, only ordered in chain
D, peptide Gln-357 forms intimate interactions with the
clamp surface as seen in the other peptide-clamp com-
plexes (Figure 3). The OE1 group forms a hydrogen
bond with a conserved solvent molecule, with the NE2
group forming two hydrogen bonds with the main chain
carbonyls of Met-362 and Pro-363 on the clamp. The
carbonyl group of Met-362 also forms a hydrogen bond
with the solvent molecule. Peptide Leu-358 does not
make any contacts with the clamp surface and is
oriented towards the solvent. The density for peptide
Asn-359 is well-defined, due to a hydrogen bond formed
between its OD1 group and the NH2 group of Arg-152 on
Table 1 Data collection and refinement statistics
All data (outer shell)
Data collection
Space group P21
Cell dimensions
a,b,c (Å) 79.5, 66.2, 82.7
α,β,γ (°) 90.0, 115.0, 90.0
Resolution (Å) 72.07-2.50 (2.64-2.50)
Rmerge 0.062 (0.284)
I/σI 7.7 (2.5)
Completeness (%) 92.1 (93.6)
Redundancy 1.9 (1.9)
Refinement
Resolution (Å) 70.00-2.50
No. of unique reflections 22294
Rcryst 23.2
Rfree 29.5
Number of atoms/au 5726
Rms deviation from ideal values:
Bond lengths (Å) 0.01
Bond angles (°) 1.37
Average temperature factors:
β-clamp (chain A/B) 21.6/21.8
Peptide (chain C/D) 27.2/26.3
Water molecules (W) 25.4
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the clamp surface. Peptide Leu-360 is located within the
hydrophobic pocket on the clamp surface defined by resi-
dues Val-247, Leu-177, Val-360, Pro-242, Met-362, with
the main chain nitrogen forming a hydrogen bond with
the carbonyl group of Gly-174.
Remarkably, and in contrast to the other peptide-
clamp complexes, peptide Phe-361 does not penetrate
the hydrophobic pocket of the clamp and is solvent ex-
posed (Figure 4). The principle interaction appears to be
hydrophobic in nature, with the hydrophobic portion of
the clamp Arg-246 side chain. Inspection of the hydro-
phobic pocket on the β-clamp typically occupied by the
peptide aromatic component suggested that the pocket
is empty in this complex. The terminal two residues of
the peptide, both aspartate, appear to be disordered. In
the context of the intact UmuC protein, they would
function as a linker between the LF domain/β-binding
motif and the CTD. Since the mode of interaction, if
any, of the UmuC CTD with the β-clamp is not known,
the possibility cannot be excluded that these residues
might provide a more intimate association in the full
length complex.
Comparison of β/UmuC peptide with the uncomplexed β-
clamp
The terminal two residues of the β-clamp (Arg-365 and
Leu-366) are modelled in the uncomplexed structure,
but are not ordered in the peptide-clamp complex. Al-
though there is a clear shift in the position of the clamp
Met-362 side chain, noted in other complexes [11], no
variation is seen in the disposition of the remaining resi-
dues comprising the hydrophobic cleft on the surface of
the clamp (Additional file 1: Figure S3). The Arg-152
guanidinium group shifts slightly in position, with the
remainder of the side chain in the same orientation and
clamp Arg-246 shows variation in its side chain orienta-
tion and is proximal to the peptide Phe361. These differ-
ences in the disposition of clamp Arg-152 and Arg-246
likely occur on complexation to the UmuC peptide fol-
lowing interactions with Asn-359 and Phe-361 of UmuC,
respectively.
Comparison with Pol II peptide
Pol II peptide (TLMTGQLGLF) was only found to bind
one subunit of the β-clamp, with crystal contacts
Dylight649-C-QGVAQLNLFDD
A
B C
D
mAu
64
50
36
kDa
Figure 2 Production of β-clamp/UmuC peptide co-crystals. A. Size exclusion traces of β-clamp protein (unbroken), UmuC peptide (dashed)
and complex (dotted), showing the expected shift in elution volume on complexation. x axis – elution volume (ml), y axis absorption OD280.
B. SDS-PAGE analysis of His-tagged β-clamp. C. β-clamp/UmuC co-crystals showing the pronounced blue colouration from the Dylight649
chromophore. D. Peptide sequence.
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occluding the other binding pocket [14]. As seen in
UmuC, Pol II possesses a 5-amino acid binding motif.
The Pol II motif is very similar to that found in UmuC
except for glycine replacing asparagine at position 359
(UmuC numbering, unless otherwise stated) (Figure 1,
Additional file 1: Figure S2). Some deviation is observed
in the refined position of the conserved glutamine side
chain of the Pol II clamp binding motif, but this is still
oriented such that it can make equivalent hydrogen
bonds to the conserved water molecule and the carbonyl
oxygen of Met-362 on the clamp (Figure 5). The orienta-
tion of the clamp His-175 side chain is altered between
the two structures, extending the distance between the
peptide Leu-358 carbonyl group and His-175 ND1 from
3.3 (β-clamp-Pol II peptide) to 3.5 Å (β-clamp-UmuC
peptide).
The Pol II peptide contains glycine at the equivalent
position to UmuC Asn-359 and a solvent molecule is
present 1.07 Å from OD1 of the UmuC asparagine. This
solvent molecule forms a rather short hydrogen bond
with NH2 of clamp Arg-152 (2.62 Å), with the side
chain in a virtually identical in position in the two struc-
tures (Figure 5). The solvent molecule also interacts with
the terminal oxygen of the Pol II peptide, absent in the
UmuC peptide.
The Pol II leucine residue equivalent to UmuC Leu-
360 is more intimately associated with the β-clamp but
shows a similar disposition and both UmuC Leu-360
and the Pol II equivalent are located within the clamp
hydrophobic pocket. The biggest variation is seen in the
terminal residue of each clamp-binding motif, conserved
in each case as a bulky aromatic residue. In the Pol II
structure the phenylalanine fits firmly into the hydro-
phobic pocket on the clamp surface, whilst in UmuC it
projects away from the surface of the clamp (Figures 4
and 5), however calculations of the β-clamp surface area
A
B
R152
M362
H175
H20
G174
A356 Q357
N320
Y323
M364
L358
M362
P363
N359
G174
H175
L360
L177
P242
V247
V360
M362
F361
R246
R152
M362
M364
H175
P363
A       Q        L         N       L               F
R246
P363
Figure 3 Interactions between the UmuC peptide and β-clamp. A. The clamp is coloured in gray and the peptide in magenta/atomic
colouring. Interacting residues are depicted in stick representation with hydrogen bonds shown as black dotted lines. Key interacting residues
from the β-clamp are labelled. B. Schematic of the peptide/clamp interactions. Backbone atoms are indicated by circles: Cα (white), C (gray),
O (red) and N (blue) with side chains in line representation. Hydrogen bonds are indicated by dashed orange line with the indicated β-clamp
residues. Proximal clamp residues are shown in blue under the respective peptide residue.
Patoli et al. BMC Structural Biology 2013, 13:12 Page 6 of 13
http://www.biomedcentral.com/1472-6807/13/12
involved in the interfaces between the two peptides are
comparable. There is a progressive deviation in the main
chain position from the conserved glutamine towards
the phenylalanine (Table 2), which is more pronounced
than variations between major β-clamp residues at the
protein-peptide interface.
Comparison with Pol III peptide complex
The sequence of the C-terminal Pol III β-binding motif
(QVELEFD) is more distant from the canonical sequence
defined by Dalrymple and others (QL[S/D]LF) [5]. The
conserved glutamine forms similar interactions to those
seen in other complex structures, with the conserved
water molecule and the backbone carbonyls of Met-362
and Pro-363 on the clamp. The Pol III valine equivalent
to UmuC Leu-358 shows a large shift in the Cα position,
resulting in the main chain nitrogen interacting with the
carbonyl group of clamp Pro-363. The two side chains
are similarly oriented.
The Pol III glutamate at the equivalent position to
UmuC Asn-359 forms a number of hydrogen bonds
with solvent molecules (Figure 6) and with the side
chain of His-175 on the clamp (observed in both peptide
chains if the side chain of His-175 in Chain B undergoes
a 180° rotation) resulting in a change in orientation of
this side chain. Two of the solvent molecules form add-
itional hydrogen bonds with the clamp Arg-152 guanidyl
Pol II Pol III
Pol IV Pol V
Figure 4 Deviations are observed in the disposition of the β-binding motif. The clamps are shown in surface form and the peptides in stick
representation, with atomic colouring. Complexes shown are: Pol II [PDB:3D1E], Pol III [PDB:3D1F], Pol IV [PDB:1UNN] and Pol V/UmuC [this
study] [7,14]. Individual figures derive from superimposed structures to yield a view of the entire binding pocket in the same orientation in each
instance, with the N-terminus of the peptides to the left of the view and the C-terminus to the right.
Q    L   N/G    L    F
Arg 152
His 175
N C
Figure 5 Comparison of the UmuC peptide with the Pol II
peptide. Only a single amino acid change in observed between the
β-binding motifs. The structures are shown in stick representation
with atomic colouring, solvent molecules are displayed as spheres.
The UmuC complex is shown with the clamp residues and
associated solvent molecules in magenta and the peptide in light
pink. The Pol II complex is shown with the clamp residues in green
and the peptide and solvent molecules in light green. Positions of
the binding motif are indicated by arrows where visible in the view.
The Gly-781/Asn-359 substitution is highlighted by a dashed circle,
indicating the presence of a solvent molecule in the Pol II structure
replacing the asparagine side chain from the UmuC peptide. The
positions of Arg-152 are identical in the two structures. The N- and
C-terminal regions of the peptide are indicated.
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group, again affecting the orientation of this side chain
compared to that seen in UmuC.
The nitrogen of the Pol III leucine equivalent to
UmuC Leu-360 forms a main chain hydrogen bond to
the carbonyl group of clamp Gly-174, as seen with
UmuC. Possessing a 6-amino acid motif, Pol III contains
an additional surface exposed glutamate residue prior to
the conserved phenylalanine. The phenylalanine, as in
Pol II, is oriented to sit in the hydrophobic pocket on
the clamp surface.
Interestingly, both Pol III and UmuC clamp-binding
motifs contain aspartate residues C-terminal to the con-
served phenylalanine residue. This aspartate is absent
from the β-clamp-UmuC peptide structure but is
modelled in the Pol III structure, with its OD1 group
forming a hydrogen bond with clamp Arg-246 (NH1).
This aspartate appears to be further stabilised by hydro-
gen bonds with the neighbouring phenylalanine carbonyl
oxygen via its main chain nitrogen and OD2 groups.
Comparison with Pol IV structures
The Pol IV β-binding motif deviates more sharply from
the canonical sequence (QLVLGL), with a glycine
allowing the peptide to bend and insert the flanking leu-
cines into the hydrophobic pocket to mimic the action
of the bulkier aromatic residues typically found in this
position [7]. The backbone of the Pol IV peptide most
closely follows that of UmuC peptide up to the glycine
equivalent to Phe-361 (Table 2), again with the UmuC
Phe-361 sitting more exposed than the Pol IV LGL motif
that mimics the conserved phenylalanine in the clamp’s
hydrophobic binding pocket. Aside from this deviation,
only subtle differences are noted; the side chain of clamp
His-175 is rotated around, presumably due to the lack of
a hydrogen bond to the main chain carbonyl of peptide
Leu-358, seen in the UmuC structure. As in the other
comparative structures the extreme C-terminal residue of
Pol IV is represented in the peptide and is ordered, in dir-
ect contrast to the internal motif of UmuC, interacting
with clamp Arg-152 via solvent molecules.
Discussion
The nature of the interaction between processivity fac-
tors and their binding partners is essentially conserved
from phage through to humans [7]. The interaction in-
volves two subsites on the surface [11]. Subsite 1 con-
sists of a hydrophobic pocket on the surface of the
processivity factor into which bacterial partners insert the
Leu-Phe motif in an extended context, with PIP proteins
inserting Phe-Phe involving a loop of 310 helix. Subsite 2
involves interactions of the conserved glutamine residue
Table 2 Cα to Cα distance (Å) between UmuC-peptide complex structures and previously solved complexes
Residue - peptide Pol II Pol III Pol IV
Ala/Gly(II)/Glu(III)/Arg(IV) 0.84 0.79 0.67
Gln 0.74 0.39 0.73
Leu/Val(III) 1.43 1.65 0.78
Asn/Gly(II)/Glu(III)Val(IV) 1.39 1.15 0.95
Leu 1.51 1.46 1.00
Phe/Gly(IV) 2.90 n/a (insertion Glu) 2.31
Residue – β-clamp Chain A (peptide associated) Chain B Chain B
D150 0.05 0.82 1.06
R152 0.18 0.81 1.05
G174 0.41 0.45 0.42
H175 0.51 0.87 1.12
The UmuC residue is indicated in bold type. For β-clamp comparisons chain B was employed in measurement and compared with the designated chain.
R152
H175
Asn/Glu
Figure 6 View of the hydrogen bonding pattern surrounding
Asn-359. Asn-359 in UmuC (magenta) and Glu-1156 in the Pol III
peptide (blue) are shown. The glutamate side chain in Pol III forms
hydrogen bonds with a network of solvent molecules (all shown
molecules relate to Pol III), which in turn interact with Arg-152 and,
potentially, the side chain of His-175, resulting in a change in
orientation of this residue. Asn-359 forms a hydrogen bond with
Arg-152 in Pol V altering its position relative to the Pol III structure.
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with solvent molecules and the backbone of the C-
terminal region of the clamps.
Given both the central role of the processivity factors
in DNA replication and repair and the sheer number of
binding partners with highly similar interaction motifs,
much attention has been given to how organisms coord-
inate binding partner activities and impose hierarchies of
interaction to control access to the processivity factor
and hence to DNA. Further modulating interfaces have
been proposed to assist in this with genetic, biochemical
and structural characterisation clearly demonstrating
that such interfaces play a crucial role [5,7,9,13,31,32].
However, a number of complexes, particularly those in-
volving binding motifs from translesion polymerases,
show subtle deviations in the mode of interaction that
may impact on the polymerase usage hierarchy [7,12].
The UmuC binding motif shows less reliance on the
hydrophobic binding motif than related peptides
Given the agreement between the UmuC binding motif
(QLNLF) and the consensus proposed by Dalrymple and
others (2001) (QL[S/D]LF), it might be supposed that
the UmuC motif would follow a very similar profile to
that seen for Pol II (QLGLF) in complex with the β-
clamp [14]. In the broadest context, the UmuC peptide
binds to β-clamp as has been observed previously, occu-
pying both binding sites on the clamp dimer, since crys-
tal packing does not occlude either site. The principle
clamp-binding peptide motif is ordered within the struc-
ture, with N-terminal elements disordered, as has been
observed previously [11]. Little deviation is seen in bind-
ing at subsite 2, with the conserved glutamine making
contact with the β-clamp backbone, both directly and
via a conserved solvent molecule. The disposition of the
two peptide leucine residues is again similar to the
known structures, although UmuC Leu-360 is not
inserted so deeply into the clamp hydrophobic pocket.
A dramatic and unique difference is seen in the con-
served phenylalanine residue of UmuC. Insertion of the
conserved phenylalanine into the clamp hydrophobic
pocket at subsite 1 is accepted to be a crucial part of the
β-clamp-binding partner interaction. Even where devi-
ation has been observed previously, in the LGL motif of
Pol IV, bending at the glycine allows the neighbouring
leucines to come into close contact and they insert into
the clamp hydrophobic pocket in a manner analogous to
the phenylalanine in other structures. The conserved
phenylalanine of the UmuC peptide does not insert into
the clamp hydrophobic pocket at all, and this arrange-
ment is reflected in the increasing deviation in Cα pos-
ition moving through the peptide, as compared to the
known complexes.
Mutational analysis of β-binding peptides typically em-
phasises the importance of the hydrophobic interaction
between the peptide Leu-Phe motif and the clamp sur-
face. Beuning and others (2006) assessed the relative
mutational frequency of various UmuC mutants. Mutat-
ing UmuC Gln-357 to alanine reduced mutagenesis
markedly, to ~20% WT levels. Interesting, mutating
Asn-359 had a more profound impact than mutating Phe-
361, reducing mutagenesis levels to ~30% and ~60%,
respectively [33]. Mutating the equivalent glutamate
(Glu-1156) in Pol III resulted in a clear reduction in β-
binding, whilst mutation of Pol III Phe-1159 eliminated
β-binding with the consequent effect that the phenyl-
alanine mutant was incapable of competing Pol III core
from the clamp, whilst the E1158A mutant was profi-
cient [15]. Mutation of Pol III Phe-924 to alanine in the
internal β-binding motif resulted in a 10-fold reduction
in affinity compared to WT, although the comparable
D922 mutation was not described in this study [20].
It appears that mutation of Phe-361 in UmuC has a
less profound effect than equivalent mutations in either
of the two Pol III β-binding motifs and, conversely, that
mutation of Asn-359 in UmuC has a more pronounced
effect than would be expected. We suggest that greater
reliance is placed upon the UmuC Asn-359 to clamp
Arg-152 interaction, since no intimate interaction exists
between UmuC Phe-361 and the clamp, with Phe-361
involvement limited instead to interaction with the
hydrophobic portion of the side chain of clamp Arg-246.
Variations occur in the β-clamp binding motifs
Detailed bioinformatics analysis of β-clamp binding mo-
tifs suggests that the central residue in the motif is most
likely to vary, with serine the most likely amino acid
(34%), followed by aspartate (23%) with other small side
chains frequently encountered [5]. Asn-359 in UmuC
forms a hydrogen bond with clamp Arg-152. The nearest
structural homologue, Pol II, possesses glycine at this lo-
cation and a solvent molecule in the position compar-
able to the asparagine side chain. Pol III has glutamate
in this position in the C-terminal β-motif; this side chain
indirectly contacts clamp Arg-152 via water molecules,
rather than forming a salt bridge, and instead interacts
with the clamp via a hydrogen bond to His-175.
A number of mutant forms of the β-clamp have been
identified that differentially affect the DNA polymerases
of E. coli. β-clamp P363S and alanine mutants in the
173–175 region have been shown to have a more pro-
found effect on Pol V function than on replication by
Pol III [34]. UmuC Gln-357 forms a hydrogen bond with
the carbonyl of clamp Pro-363 and the main chain
amine group of UmuC Leu-360 interacts with the car-
bonyl of clamp Gly-174. The Pol III peptide shows the
same interaction with clamp Pro-363, and a main chain
interaction between Pol III Leu-1157 and clamp Gly-174
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[14], suggesting that these interactions are more crucial
to maintaining UmuC binding than Pol III.
It is clear from this study that, despite good agreement
with the consensus sequence, variation in β-clamp bind-
ing is observed between the β-binding motifs of the E.
coli polymerases. Although the peptides are not
presented in the context of full length proteins which
has been postulated to affect binding [11], it seems likely
that these subtle variations in binding affect polymerase
usage hierarchy and are influenced by key residues on
the clamp surface. Detailed inspection of the complex
structures shows that Arg-152 and His-175 on the clamp
surface are particularly variable in their position. Arg-
152, in particular, varies in terms of interaction with the
peptides. Arg-246 also varies in position and interaction,
though to a lesser extent.
Interaction with Arg-152 and His-175 is affected by
deviations in the binding motif
The central residues of the β-binding motif and the
motif location on the protein, i.e. internal or C-terminal,
appear to be the principal determinants of the position
of both His-175 and Arg-152 in the clamp. For example,
clamp His-175 is altered in complex with Pol III due to
contact with Pol III Glu-1154, with only water-mediated
interactions between Pol III residues and clamp Arg-152.
In UmuC, Asn-359 is physically much closer to clamp
Arg-152 due to the increasing deviation in position of the
peptide backbone, and may indeed influence this devia-
tion. The terminal oxygen of Pol II forms a water medi-
ated interaction with clamp Arg-152, as does the terminal
oxygen of Pol IV, but the six residue clamp-binding motif
of Pol IV results in a greater shift in the clamp Arg-152
position.
Biochemical and genetic analyses have highlighted
His-175 and Arg-152 as playing an important role in β-
clamp function in the cell. Both residues exist in surface
exposed loops and alanine mutants of clamp residues
173–175, also incorporating the key Gly-174 residue,
and 148–152 have given insight into polymerase usage
hierarchies [31,34]. The β-clamp 148–152 loop was
shown to be critically important for Pol V function
in vivo, as well as clamp Pro-363 as mentioned above.
Individual clamp mutants including Arg-152 were
analysed, but were thought to produce changes insuffi-
cient to interfere with mutagenesis in vivo [34]. Com-
parison of the single G174A and 173–175 clamp
mutants, which result in distinct UV-sensitive pheno-
types, suggested differential effects on the polymerases
and it was proposed that in these mutants, Pol IV could
gain control of the replication fork ahead of Pol V, which
likewise would replicate in preference to Pol II.
Complicating matters further, clamp Arg-152 has been
shown to contact the nascent DNA duplex when the β-
clamp is bound to a primer-template terminus, with
Gly-174 also making contact [3]. Neuwald proposed in
2003 that Gln-149 could function by sensing DNA
within the pore of the clamp and relaying the informa-
tion back to the peptide binding site [35] (Figure 7). A
co-crystal structure of the β-clamp in complex with a
primer-template terminus demonstrated interaction be-
tween Gln-149 and the oligonucleotide. The principle
defect of Q149A in Pol III-mediated replication
appeared to be at the clamp loading stage rather than
elongation [3], also noted for the 148–152 clamp mutant
[36], presumably due to a defect in DNA binding
impacting on subsequent clamp loading at the primer
terminus. In contrast the β-clamp 148–152 loop was
shown to be crucial for both interaction with Pol II and
IV and associated replication [36]. These results are con-
sistent with the proposed relay of information upon
DNA-binding to clamp Gln-149, via the conserved Asp-
150 which hydrogen bonds extensively to Arg-152 [35].
D150N was isolated as a clamp mutant affecting action
of the umuDC gene products [37]. Pol V is a classic ex-
ample of the complexity of dissecting protein interac-
tions and hence regulation; beyond the canonical binding
motif described here, interactions have been characterised
in the Pol V LF domain and sites at Arg-230, Thr-243 and
within the CTD, at Leu-389 [33,38]. Additionally, the
UmuD and UmuD’ proteins bind β-clamp directly and
pore Arg-
152
Asp-
150
Gln-149
C
N
Figure 7 The proposed communication relay between the β-
clamp pore to the peptide binding site. Gln-149 is proposed to
act as a DNA sensor, impacting on the conformation of Asp-150,
which in turn substantially interacts with Arg-152, a key clamp
residue involved in peptide binding. The co-complex presented has
been aligned with the β-clamp/DNA co-crystal structure [PDB:3BEP].
The β-clamps are shown in cartoon form in light blue (UmuC
complex) and cyan (DNA complex), with the 148–152 loop shown in
stick representation in atomic colouring. The UmuC peptide is
shown in magenta, with key hydrogen bonds represented by black
dashed lines. DNA is coloured red. The N- and C-terminal regions of
the peptide are indicated.
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truncation of the UmuD protein to UmuD’ is itself crucial
to regulation of Pol V activity [37].
The UmuC binding motif is internal to the protein
One point of interest is that, unusually, although not
uniquely, the UmuC clamp-binding motif is internal,
lying between the LF domain and the CTD (the latter
currently of unknown function). The UmuC peptide was
designed to possess the two aspartate residues C-
terminal to Phe-361, leading into the UmuC CTD. It
seems likely that it is this arrangement which influences
the unusual position of the UmuC Phe-361. The Pol III
C-terminal peptide has one aspartate residue at the ex-
treme C-terminus. In contrast to that seen in UmuC, for
which no density was observed, the terminal residue of
the Pol III peptide was well ordered, presumably a re-
flection of the intimate contact made between the clamp
Arg-246 and the preceding phenylalanine in the peptide
[14]. Presumably Asp-362 and Asp-363 do not form suf-
ficiently stable contacts with the clamp surface for elec-
tron density to be observed. As has been observed
previously, although many PIP box-containing proteins
form a section of β-sheet with the interdomain con-
nector loop of PCNA, this arrangement is precluded in
the β-clamps by an insertion between the first helix and
second strand in the second domain [7]. Therefore the
presence of these residues is likely to be the main deter-
minant for the lack of penetration of Phe-361 into the
hydrophobic pocket.
It must also be considered that the UmuC CTD may
contact the clamp, presumably in the region of domain
2. In the context of the full length protein this region
may be less mobile in complex than observed in the
peptide-protein co-crystal. The β-binding motif of the δ
subunit of the clamp loader is internal and this results in
the residues C-terminal to the conserved phenylalanine
forming a turn back into the globular fold of the δ sub-
unit [39]. In the two polymerases where the terminal
residue of the clamp-binding motif is the extreme
terminus of the protein (II and IV) the terminal oxygen
groups both form water-mediated interactions with
clamp Arg-152.
Interestingly, the other human translesion polymerase
containing an internal PIP box, Pol ι, also shows devi-
ation in the nature of its binding to the hydrophobic
pocket of PCNA [12]. Pol ι possesses two tyrosine resi-
dues, with the unusual interaction between the hydroxyl
group of Pol ι Tyr-427 and the carbonyl group of the ly-
sine (412) substituting for the conserved glutamine in
the peptide.
Implications of variation
Clearly β-clamp surface residues affect the behaviour of
the various clamp-binding peptide motifs, particularly
Arg-152 and to a lesser extent, His-175. The subtle dif-
ferences between these motifs are particularly relevant
when considering the β-clamp as a potential antibiotic
drug target. Full characterisation of key binding partners
is critical to a successful outcome, since structural pre-
diction is unlikely to highlight the type of differences ob-
served in the crystal structure of the UmuC peptide with
the β-clamp. Variation in binding between the polymer-
ases has already been demonstrated to alter the efficacy
of trial drugs, since RU7 is 50-fold less effective on Pol
IV than Pol III, presumably reflecting the divergent Leu-
Gly-Leu motif the former possesses over the canonical
Leu-Phe motif of the latter [14]. The multiple peptide
and drug complexes now available have highlighted
clamp residues critical to binding that could be optimised
for enhanced inhibitor binding, such as Arg-152 and Arg-
246 [14,22] .
Conclusion
Analysis of polymerase interaction with the β-clamp is
complex, particularly when considering the multimeric
Pol III and Pol V. It is increasingly apparent that subtle
variation in the β-clamp binding motif in conjunction
with modulating, non-overlapping interfaces of various
binding partners plays a central role in determining this
hierarchy and that direct binding of DNA by the clamp
differentially influences polymerase binding. The struc-
ture presented here demonstrates the importance of
characterisation of motifs at atomic level, despite their
apparent agreement with consensus sequences. Asn-359
of UmuC plays an unexpectedly crucial role in β-clamp
binding, owing to direct interactions with clamp residue
Arg-152, with the conserved Phe-361 in UmuC playing
a less significant role, presumably due to the context of
the motif within the protein sequence. Understanding
these processes is relevant to the characterisation of the
fundamental process of DNA replication and dissection
of the regulation of mutagenesis, impacting on the adap-
tation of bacterial pathogens, and the development of
next generation antibiotics.
Additional file
Additional file 1: Figure S1. Omit density maps showing the peptide
(chain D) in stick representation. The surface of the β-clamp is shown in
magenta, with the 2Fo-Fc density map in grey, contoured at 1σ and the
Fo-Fc map in dark blue, contoured at 3 σ. Figure S2. Summary of key
interactions between clamp-binding peptide motifs of E. coli polymerases
and the β-clamp. Dashed lines show interactions (direct or solvent-
mediated) discussed in this manuscript. Asterisks indicate residues
forming the β-clamp hydrophobic binding pocket. (≡) denotes
equivalent residue in the UmuC clamp-binding peptide for comparison.
More detailed representation of interactions between UmuC and the
β-clamp is shown in Figure 3. Figure S3. Superposition of the UmuC
complex (magenta/light pink) with the uncomplexed β-clamp (orange).
Met-362 is indicated with a red dotted ring.
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